시장보고서
상품코드
91227

중국의 혈액 질환 치료제 시장

Blood Disease Drugs Markets in China

발행일: | 리서치사: Asia Market Information & Development Co. | 페이지 정보: 영문 290 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

중국의 혈액 질환 치료제 시장에 대해 조사분석했으며, 수요와 업계 동향의 예측 및 사업 환경, 시장 참여에 관한 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 조사 범위와 조사 방법
  • 주요 요약

제2장 사업 환경

  • 경제 전망
  • 주요 경제지표
  • 산업 생산
  • 인구와 노동력
  • 외국 투자
  • 외국 무역
  • 재무와 세금 규제
  • 은행 시스템과 규제
  • 외환
  • 세금과 관세

제3장 혈액 질환 치료제 업계 평가

  • 혈액 질환 치료제 업계의 구조
  • 시장 규모
  • 시장 성장 촉진요인
  • 혈액 질환 치료제 판매량
  • 주요 생산 시설 장소와 판매량
  • 주요 생산자의 시장 점유율
  • 인건비
  • 잠재적 참여 기업
  • 주요 판매업체
  • 주요 외국 투자
  • 기술개발

제4장 혈액 질환 치료제 생산과 수요

  • 개요
  • 혈액 질환 치료제의 수요 : 지역별
  • 혈액 질환 치료제 판매량
  • 빈혈 치료제
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • 호중구감소증과 무과립구증 치료제
  • 비타민 B4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • 부신피질 호르몬
  • 과립구집락자극인자(G-CSF)
  • 백혈병 치료제 판매량
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • 기타 혈액 질환 치료제 판매량
  • 혈액 질환 치료제 수입
  • 백혈병 치료제 수입
  • 기타 혈액 질환 치료제 수입
  • 가격 동향

제5장 혈액 질환 치료제 시장 전망

  • 혈액 질환 치료제 시장 전망의 개요
  • 정부 규제
  • 의료보험 업계의 개요
  • 소비자 지출의 동향
  • 북동
  • 북부
  • 남동
  • 중부
  • 남서
  • 북서
  • 인구통계의 동향
  • 의료 업계의 동향
  • 병원과 병상

제6장 마케팅 전략

  • 중국 시장 진출의 개요
  • 중국의 유통 시스템
  • 혈액 질환 치료제 유통 채널
  • 운송과 화물 인프라
  • 커뮤니케이션
  • 중국 시장 진출
  • 라이선싱
  • 프랜차이즈
  • E-Commerce
  • 상사와 현지 대리점
  • 주재원 사무소와 중국의 자회사
  • 완전 외자 기업

제7장 혈액 질환 치료제 생산자 디렉토리

  • 혈액 질환 치료제 생산자 개요
  • 판매업체, 상사
  • 연구기관, 협회
KSA 23.01.12

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations
  • ULIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제